TY - JOUR
T1 - Functional monolithic platforms: Chromatographic tools for antibody purification
AU - Barroso, Telma
AU - Hussain, Abid
AU - Roque, Ana Cecília Afonso
AU - Ricardo, Ana Isabel Nobre Martins Aguiar de Oliveira
N1 - Sem PDF.
The authors would like to thank the financial support from Fundacao para a Ciencia e Tecnologia, Portugal, through contracts PEst-C/EQB/LA0006/2011, MIT-Pt/BS-CTRM/0051/2008, PTDC/EBB-BIO/102163/2008, PTDC/EBB-BIO/098961/2008 and PTDC/EBB-BIO/118317/2010 and doctoral grants SFRH/BPD/34768/2007 (A. H.), and SFRH/BD/62475/2009 (T. B.). MIT-Portugal Program Bioengineering Systems Focus Area, Fundacao Calouste Gulbenkian, FEDER and FSE.
PY - 2013
Y1 - 2013
N2 - Polymer monoliths are an efficient platform for antibody purification. The use of monoclonal antibodies (mAbs) and engineered antibody structures as therapeutics has increased exponentially over the past few decades. Several approaches use polymer monoliths to purify large quantities of antibody with defined clinical and performance requirements. Functional monolithic supports have attracted a great deal of attention as they offer practical advantages for antibody purification, such as more rapid analysis, smaller sample volume requirements and the opportunity for a greater target molecule enrichment. This review focuses on the development of synthetic and natural polymer-based monoliths for antibody purification. The materials and methods employed in monolith production are discussed, highlighting the properties of each system. We also review the structural characterization techniques available using monolithic systems and their performance under different chromatographic approaches to antibody capture and release. Finally, a summary of monolithic platforms developed for antibody separation is presented, as well as expected trends in research to solve current and future challenges in this field. This review comprises a comprehensive analysis of proposed solutions highlighting the remarkable potential of monolithic platforms.
AB - Polymer monoliths are an efficient platform for antibody purification. The use of monoclonal antibodies (mAbs) and engineered antibody structures as therapeutics has increased exponentially over the past few decades. Several approaches use polymer monoliths to purify large quantities of antibody with defined clinical and performance requirements. Functional monolithic supports have attracted a great deal of attention as they offer practical advantages for antibody purification, such as more rapid analysis, smaller sample volume requirements and the opportunity for a greater target molecule enrichment. This review focuses on the development of synthetic and natural polymer-based monoliths for antibody purification. The materials and methods employed in monolith production are discussed, highlighting the properties of each system. We also review the structural characterization techniques available using monolithic systems and their performance under different chromatographic approaches to antibody capture and release. Finally, a summary of monolithic platforms developed for antibody separation is presented, as well as expected trends in research to solve current and future challenges in this field. This review comprises a comprehensive analysis of proposed solutions highlighting the remarkable potential of monolithic platforms.
KW - Downstream processing
KW - Monolithic platforms
KW - Antibody purification
KW - Polymeric monoliths
KW - Antibody purification
KW - Downstream processing
KW - Monolithic platforms
KW - Polymeric monoliths
U2 - 10.1002/biot.201200328
DO - 10.1002/biot.201200328
M3 - Article
C2 - 23650265
SN - 1860-6768
VL - 8
SP - 671
EP - 681
JO - Biotechnology Journal
JF - Biotechnology Journal
IS - 6(SI)
ER -